Inflammatory bowel disease: cause and immunobiology.
Lancet. 2007; 369: 1627-1640
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Lancet. 2018; 390: 2769-2778
An overview of the innate and adaptive immune system in inflammatory bowel disease.
Inflamm Bowel Dis. 2017; 23: 2-13
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.
BMC Microbiol. 2011; 11: 7
Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management.
J Crohn’s Colitis. 2017; 11: 769-784
ECCO guidelines on therapeutics in Crohn’s disease: medical treatment.
J Crohn’s Colitis. 2020; 14: 4-22
Factors influencing disability and quality of life during treatment: a cross-sectional study on IBD patients.
Gastroenterol Res Pract. 2019; 20195354320
Work productivity loss in inflammatory bowel disease patients in Turkey.
Gastroenterol Res Pract. 2020; 20206979720
The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment.
Lancet Gastroenterol Hepatol. 2019; 4: 632-642
Health status and health care use in persons with inflammatory bowel disease: a national sample.
Dig Dis Sci. 1991; 36: 1746-1755
Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.
Inflamm Bowel Dis. 2006; 12: 38-46
Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients.
Dig Dis Sci. 2010; 55: 724-732
Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease.
Clin Gastroenterol Hepatol. 2016; 14: 829-835
Association between affective-cognitive symptoms of depression and exacerbation of Crohn’s disease.
Am J Gastroenterol. 2016; 111: 864-870
Crohn’s disease: a two-year prospective study of the association between psychological distress and disease activity.
Dig Dis Sci. 2004; 49: 492-497
Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease.
Gastroenterology. 2018; 154: 1635-1646
Anxiety but not depression predicts poor outcomes in inflammatory bowel disease.
Inflamm Bowel Dis. 2019; 25: 1255-1261
Mental health costs of inflammatory bowel diseases.
Inflamm Bowel Dis. 2021; 27: 40-48
State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting.
Int J Clin Pract. 2008; 62: 1063-1069
Depression and anxiety in inflammatory bowel disease in remission.
Eur Psychiatry. 2012; 27: 1
Hospital Anxiety and Depression Scale (HADS): validation in Mexican patients with inflammatory bowel disease.
Gastroenterol Hepatol. 2018; 41: 477-482
Depression and inflammatory bowel disease patients: a tertiary care center experience.
Gastroenterology. 2011; 140: S-784
Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review.
Inflamm Bowel Dis. 2007; 13: 225-234
Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.
Inflamm Bowel Dis. 2012; 18: 2301-2309
Psychiatric illness in patients with inflammatory bowel disease.
Gut. 1987; 28: 1600-1604
Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life.
J Res Med Sci. 2015; 20: 577-584
Psychological impact of Crohn’s disease on patients in remission: anxiety and depression risks.
Rev Esp Enferm Dig. 2009; 101: 249-257
Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disorders.
J Clin Gastroenterol. 2013; 47: e38-e44
Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission.
Int J Colorectal Dis. 2014; 29: 1285-1290
Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases.
Inflamm Bowel Dis. 2016; 22: 752-762
Depression and anxiety in patients with inflammatory bowel disease: a systematic review.
J Psychosom Res. 2016; 87: 70-80
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
Measuring inconsistency in meta-analyses.
BMJ. 2003; 327: 557-560
Bias in meta-analysis detected by a simple, graphical test.
BMJ. 1997; 315: 629-634
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.
BMJ. 2011; 343d4002
Is depression associated with more emergency visits in inflammatory bowel disease?.
J Crohn’s Colitis. 2014; 8: S146
Stress, anxiety and depression in patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
PSEG. 2008; 36 : 56-62
Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease.
Scand J Gastroenterol. 2002; 37: 450-457
Determinants of life satisfaction in inflammatory bowel disease.
Inflamm Bowel Dis. 2005; 11: 272-286
Processos de enfrentamento do estresse e sintomas depressivos em pacientes portadores de retocolite ulcerativa idiopática.
Rev Esc Enferm USP. 2006; 40: 507-514
Intangible costs and benefits of ulcerative colitis surveillance: a patient survey.
Dis Colon Rectum. 2006; 49: 1177-1183
Stressful life events as a risk factor for inflammatory bowel disease onset: a population-based case-control study.
Am J Gastroenterol. 2007; 102: 122-131
Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity.
J Psychosom Res. 2008; 64: 139-148
Which patients with IBD need psychological interventions? A controlled study.
Inflamm Bowel Dis. 2008; 14: 1273-1280
Comparative complexity of Crohn’s disease (CD) compared to ulcerative colitis (UC) in a metropolitan hospital setting: effects of gender and disease activity.
Gastroenterology. 2009; 136: A-656
Psychological distress in Brazilian Crohn’s disease patients: screening, prevalence, and risk factors.
Med Sci Monit. 2009; 15: PH101-PH108
Chronisch entzündliche Darmerkrankungen als multifokale Erkrankungen: körperliche und psychosoziale Probleme von Patienten mit CED. Ergebnisse eines Fragebogen-Surveys.
Z Gastroenterol. 2010; 48: 381-391
Fibromyalgia-like symptoms in inflammatory bowel disease.
Gastroenterology. 2010; 138: S-533
Evaluation of the correlation between anxiety, depression and personality traits with immunologic markers (ANCAs) in ulcerative colitis.
Iran Assoc Gastroenterol Hepatol Shiraz Univ Med Sci. 2011; 16: 91-97
Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population.
Inflamm Bowel Dis. 2011; 17: 621-632
Determinants contributing to fatigue in IBD patients.
Gastroenterology. 2011; 140: S-783-S-784
Do inflammatory bowel disease patients with anxiety and depressive symptoms receive the care they need?.
J Crohn’s Colitis. 2012; 6: 68-76
Depression and risk factors in patients with Crohn’s disease.
J Korean Acad Nurs. 2012; 42: 207-216
Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
J Crohn’s Colitis. 2013; 7: 355-368
Better disease specific patient knowledge is associated with greater anxiety in inflammatory bowel disease.
J Crohn’s Colitis. 2013; 7: e214-e218
The influence of depression on quality of life in patients with inflammatory bowel disease.
Inflamm Bowel Dis. 2013; 19: 1732-1739
Influence of anxiety and depression in the clinical course of inflammatory bowel disease patients.
J Crohn’s Colitis. 2014; 8: S149
Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity.
Aliment Pharmacol Ther. 2014; 39: 811-822
Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease.
Inflamm Bowel Dis. 2014; 20: 92-102
Effect of anti-TNFα therapy on prevalence of depression in patients with inflammatory bowel disease.
Gastroenterology. 2014; 146: S-779
Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission.
Int J Colorectal Dis. 2014; 29: 1285-1290
Clinical predictors of moderate depression and suicidality in adults with IBD.
Inflamm Bowel Dis. 2014; 20: S5
Sexual dysfunctions in men and women with inflammatory bowel disease: the influence of IBD-related clinical factors and depression on sexual function.
J Sex Med. 2015; 12: 1557-1567
Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease.
World J Gastroenterol. 2015; 21: 6713-6727
Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life.
J Res Med Sci. 2015; 20: 577-584
Unrecognized psychiatric disease in patients with inflammatory bowel disease (IBD): patients with worse IBD specific patient reported outcome measures demonstrate increased anxiety and depression scores even without a psychiatric history.
Gastroenterology. 2016; 150: S166-S167
Inflammatory bowel disease and psychological status: determinants and social consequences.
Gastroenterology. 2016; 150S1004
Employment status, difficulties at work and quality of life in inflammatory bowel disease patients.
Eur J Gastroenterol Hepatol. 2016; 28: 1130-1136
Quality of life is related to fecal calprotectin concentrations in colonic Crohn disease and ulcerative colitis, but not in ileal Crohn disease.
Medicine (Baltimore). 2016; 95e3477
Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity, in inflammatory bowel disease.
Am J Gastroenterol. 2016; 111: 541-551
Faecal incontinence in inflammatory bowel disease and its association with anxiety and depression in an Irish tertiary centre.
J Crohn’s Colitis. 2016; 10 : S496
Factors associated with anxiety and depression in Korean patients with inactive inflammatory bowel disease.
Gut Liver. 2016; 10: 399-405
Risk factors for suicidality amongst depressed IBD patients.
Inflamm Bowel Dis. 2016; 22: S15
Prevalence of anxiety and depression in patients with inflammatory bowel disease.
Can J Gastroenterol Hepatol. 2017; 20176496727
Depressive symptoms predict anti-tumor necrosis factor therapy noncompliance in patients with inflammatory bowel disease.
Dig Dis Sci. 2017; 62: 3563-3567
Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability.
Dig Liver Dis. 2017; 49: 1314-1319
Illness perceptions and coping with health-related quality of life in patients with inflammatory bowel disease.
J Crohn’s Colitis. 2017; 11: S229-S230
Vitamin D deficiency is not associated with depression in IBD patients.
J Crohn’s Colitis. 2017; 11: S444-S445
Correlation between physician and patient disease assessments in ulcerative colitis: baseline data from the ICONIC study of 1816 patients in 33 countries.
J Crohn’s Colitis. 2017; 11: S259-S260
Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: the IBSEN study.
Scand J Gastroenterol. 2017; 52: 351-358
Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease.
Patient Prefer Adherence. 2016; 11: 23-31
Resilience is associated with lower rates of depression and anxiety, and higher quality of life in inflammatory bowel disease patients.
Gastroenterology. 2017; 152: S797-S798
Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients.
J Crohn’s Colitis. 2017; 11: 165-174
Inflammatory bowel disease: impact on scores of quality of life, depression, and anxiety in patients attending a tertiary care center in Brazil.
Arq Gastroenterol. 2018; 55: 202-207
Psychosexual dysfunction in Greek patients with inflammatory bowel disease in remission.
J Crohn’s Colitis. 2018; 12: S374-S375
Complementary and alternative medicine in Brazilian patients with inflammatory bowel diseases.
Am J Gastroenterol. 2018; 113: S23
Depression is associated with more aggressive inflammatory bowel disease.
Am J Gastroenterol. 2018; 113: 80-85
Validation of the PHQ-9 for suicidal ideation in persons with inflammatory bowel disease.
Inflamm Bowel Dis. 2018; 24: 1641-1648
Assessment of quality of life in Chinese patients with inflammatory bowel disease and their caregivers.
Inflamm Bowel Dis. 2018; 24: 2039-2047
Influences and impact of anxiety and depression in the setting of inflammatory bowel disease.
Inflamm Bowel Dis. 2018; 24: 2303-2308
Reduced unplanned care and disease activity and increased quality of life after patient enrollment in an inflammatory bowel disease medical home.
Clin Gastroenterol Hepatol. 2018; 16: 1777-1785
Alexithymia and psychopathology in patients suffering from inflammatory bowel disease: arising differences and correlations to tailoring therapeutic strategies.
Front Psychiatry. 2018; 9: 324
A comparison of the prevalence of anxiety and depression between uncomplicated and complex IBD patient groups.
Gastroenterol Nurs. 2018; 41: 427-435
Longitudinal trajectory of fatigue with initiation of biologic therapy in inflammatory bowel diseases: a prospective cohort study.
J Crohn’s Colitis. 2020; 14: 309-315
The influence of disease type and activity to sexual life and health quality in inflammatory bowel disease.
Turk J Gastroenterol. 2019; 30: 33-39
Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease.
Saudi J Gastroenterol. 2019; 25: 159-166
Psychiatric outcomes are significantly impacted with inflammatory bowel disease and comorbid nonalcoholic fatty liver disease.
Gastroenterology. 2019; 156: S-441
Anxiety, depression, and disability in patients with inflammatory bowel disease.
J Gastroenterol Hepatol. 2019; 34: 120
Female gender increases the risk of anxiety and depression in patients with inflammatory bowel disease under anti-TNFα therapy.
J Crohn’s Colitis. 2019; 13: S216
Integrated psychological care is needed, welcomed and effective in ambulatory inflammatory bowel disease management: evaluation of a new initiative.
J Crohn’s Colitis. 2019; 13: 819-827
Crohn’s disease patients with depression exhibit alterations in monocyte/macrophage phenotype and increased proinflammatory cytokine production.
Dig Dis. 2020; 38: 211-221
Factors associated with depression in people with inflammatory bowel disease: the relationship between active disease and biases in neurocognitive processing.
Neurogastroenterol Motil. 2019; 31e13647
Important relation between self-efficacy, sense of coherence, illness perceptions, depression and anxiety in patients with inflammatory bowel disease.
Frontline Gastroenterol. 2020; ()
Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease: a nursing-led cross-sectional study of patients in clinical remission.
Medicina (Kaunas). 2020; 56: E45
The hospital anxiety and depression scale.
Acta Psychiatr Scand. 1983; 67: 361-370
Depression and anxiety in people with inflammatory bowel disease.
J Epidemiol Community Health. 2001; 55: 716-720
Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease.
Am J Gastroenterol. 2002; 97: 1994-1999
Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease.
Aliment Pharmacol Ther. 2017; 46: 225-235
The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease.
Inflamm Bowel Dis. 2018; 24: 1867-1875
The prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with inflammatory bowel disease.
Inflamm Bowel Dis. 2019; 25: 1674-1680
Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case-control study.
Gut. 2020; ()
Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression.
Gut. 2019; 68: 1606-1612
Psychological distress, social support, and disease activity in patients with inflammatory bowel disease.
Am J Gastroenterol. 2001; 96: 1470-1479
Review article: how to control and improve adherence to therapy in inflammatory bowel disease.
Aliment Pharmacol Ther. 2006; 24: 45-49
Integrated psychological care reduces health care costs at a hospital-based inflammatory bowel disease service.
Clin Gastroenterol Hepatol. 2021; 19: 96-103